PMC3357138_01
a Fundus photography at baseline, before Ozurdex  injection, shows cystoid ME, widespread hemorrhaging and a swollen optic nerve in a vitrectomized eye. b Fundus photography 6 months after treatment shows a resolution of intraretinal hemorrhages and no ME.
cop-0003-0030-g01.jpg
PMC3357138_01_cop-0003-0030-g01.jpg
F1
When the patient was first examined at our clinic, 6 months after vitrectomy, she was diagnosed with cystoid ME secondary to CRVO (fig. 1a).
a Baseline Spectralis OCT, before Ozurdex  injection, shows cystoid ME, refractory to 2 injections of Avastin , in a vitrectomized eye; central retinal thickness was 672 mum. b Seven days after the injection of Ozurdex, using the follow-up function, OCT shows a 389-mum reduction in central retinal thickness. c Follow-up examination 180 days after Ozurdex injection. OCT shows the resolution of ME with a 469-mum reduction in central retinal thickness, compared to the baseline value.
cop-0003-0030-g02.jpg
PMC3357138_01_cop-0003-0030-g02.jpg
F2
BCVA in the right eye was 1.2 logMAR and central foveal thickness was 672 mum as measured by SD-OCT (spectral domain optical coherence tomography; Spectralis, Heidelberg Engineering, Heidelberg, Germany) (fig. 2a).